Research Advisory Council (RAC)


PCC is advised and counseled by a Research Advisory Council (RAC) that comprises prominent prostate cancer researchers. The role of RAC is to:
  • Synthesize the results of the peer review process and make recommendations for funding to senior PCC staff
  • Receive reports of the evaluation of PCC research programs and provide advice on the development of new programs and the ongoing improvements to existing programs
  • Lead the identification of strategic research areas that could be targeted with specific Requests For Applications
  • Evaluate the PCC peer review processes and recommend necessary enhancements on an ongoing basis
  • Recommend membership of peer review panels
  • Identify potential national and international opportunities for collaboration
  • Provide advice in the development and refinements of scientific and administrative policies
The Council will be composed of established prostate cancer researchers who:
  • Collectively represent expertise in all areas of prostate cancer research
  • Are broadly representative of all major regions in Canada
  • Individually have a strong track record in peer-reviewed research funding and research output
In addition, the Council will include 2 non-scientific members, one of whom must be a prostate cancer patient or survivor. Each will be identified and selected through a formal nomination process.

Current Membership

Alison Allan,Western University, London, ON
David Berman, Queen's Cancer Research Institute, Kingston, ON
Paul Boutros, Ontario Institute for Cancer Research (OICR), Toronto
, ON
Ralph Buttyan, Vancouver Prostate Centre, Vancouver, BC
Kim Chi, BC Cancer Agency, Vancouver, BC
Michael Cox, University of British Columbia, Vancouver, BC

Stuart Edmonds (Ex Officio), Prostate Cancer Canada, Toronto, ON
Masoom Haider, Mount Sinai Hospital, Toronto, ON
Anne Katz, Manitoba Prostate Centre, Winnipeg, MB
Winston Klass, Community Representative, Concord, ON
John Lewis, University of Alberta, Edmonton, AB
Mathieu Lupien, Princess Margaret Cancer Centre, Toronto, ON
Randy Mellow, Community Representative, Peterborough, ON

Cynthia Ménard, Centre hospitalier de l'Université de Montréal, Montreal, QC
Ian G.Mills, Queen's University Belfast, Belfast, UK
Fred Saad, Université de Montréal, Montreal, QC
Gurmit Singh (Scientific Chair), McMaster University, Hamilton, ON

Danny Vesprini, Sunnybrook Research Institute, Toronto, ON
Katherine Zukotynski, McMaster University, Hamilton, ON

As of June 28, 2018

 


 


Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More

Prostate Cancer Canada launches first national program in radioligand therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More


Click here for news archive